| Title : Metabolic Characterization of Sarin, Cyclosarin, and Novichoks (A-230, A-232) in Human Liver Microsomes - Lane_2025_Chem.Res.Toxicol_38_353 |
| Author(s) : Lane TR , Koebel DD , Lucas EA , Cleary S , Moyer R , Ekins S |
| Ref : Chemical Research in Toxicology , 38 :353 , 2025 |
|
Abstract :
We have assessed the human liver microsomal (HLM) metabolism of the chemical warfare nerve agents' sarin (GB), cyclosarin (GF), and the Novichok agents A-230 and A-232. In HLM, GB showed drastically decreased stability (t(1/2) = 1.4 h). The addition of ethylenediaminetetraacetic acid (EDTA), which inhibits paraoxonase-1 (PON1), reduced the metabolism of GB in HLM suggesting at least a partial role in its metabolism (t(1/2) = 2.6 h). The absence of NADPH (a requirement for CYP activity) had a major impact on metabolism, suggesting a role of likely CYP-mediated metabolism, which was rescued with the later addition of NADPH at 4 h. GF was also metabolized readily in HLM (Control t(1/2) = 9.7 h; HLM t(1/2) = 0.5 h), and this metabolism was mitigated by the addition of EDTA (t(1/2) (fast) = 0.7 h, t(1/2) (slow) = 4.0 h), suggesting a PON1 role in the metabolism of GF. GF in HLMs also showed a reduced metabolism without NADPH, suggesting a CYP-mediated role. We have described for the first time the clearance of A-230 in HLM (t(1/2) (fast) = 0.9 h, t(1/2) (slow) = 26.5 h), with a significantly decreased stability from the control (t(1/2) = 48.3 h) and with the formation of the A-230 acid as the major metabolite. EDTA also reduced the metabolism of A-230 in HLMs (t(1/2) (fast) = 0.8 h, t(1/2) (slow) = 62 h). A-232 metabolism was also HLM-dependent (t(1/2) (fast) = 1.2 h, t(1/2) (slow) = 1190 h), although overall it was dramatically more stable in the control (t(1/2) = 2,300 h). The metabolism of A-232 in HLMs also showed some inhibition by EDTA (t(1/2) (fast) = 0.5 h, t(1/2) (slow) = 1480 h). |
| PubMedSearch : Lane_2025_Chem.Res.Toxicol_38_353 |
| PubMedID: 39811973 |
| Gene_locus related to this paper: human-NLGN3 |
| Mutation | R451C_mouse-3neur R451C_human-NLGN3 |
| Gene_locus | human-NLGN3 |
| Disease | Neuroligin 3 Autism AUTSX1 Asperger syndrome ASPGX1 |
Lane TR, Koebel DD, Lucas EA, Cleary S, Moyer R, Ekins S (2025)
Metabolic Characterization of Sarin, Cyclosarin, and Novichoks (A-230, A-232) in Human Liver Microsomes
Chemical Research in Toxicology
38 :353
Lane TR, Koebel DD, Lucas EA, Cleary S, Moyer R, Ekins S (2025)
Chemical Research in Toxicology
38 :353